AMIGORENA; Sebastian

Patent Applications and Registrations

Patent applications and USPTO patent grants for AMIGORENA; Sebastian.The latest application filed is for "immune cells defective for suv39h1".

Company Profile

12.7.18

AMIGORENA; Sebastian - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immune Cells Defective For Suv39h1 App 20220251572 - AMIGORENA; Sebastian ; et al.	2022-08-11
Interleukin-2 Variants with Modified Biological Activity App 20220193198 - PIAGGIO; Eliane ; et al.	2022-06-23
Immune cells defective for Suv39h1 Grant 11,285,176 - Amigorena , et al. March 29, 2	2022-03-29
Immune Cells Defective For Suv39h1 App 20220040235 - AMIGORENA; Sebastian ; et al.	2022-02-10
Anti-LSP1 antibody Grant 10,968,281 - Segura , et al. April 6, 2	2021-04-06
Agonist Of Aryl Hydrocarbon Receptor For Use In Cancer Combination Therapy App 20210060158 - Amigorena; Sebastian ; et al.	2021-03-04
Lentiviral Vectors For Regulated Expression Of A Chimeric Antigen Receptor Molecule App 20210009653 - AGAUGUE; Sophie ; et al.	2021-01-14
Inhibitor Of Setdb1 Histone Methyltransferase For Use In Cancer Combination Therapy App 20200405853 - AMIGORENA; Sebastian ; et al.	2020-12-31
Dap10/12 Based Cars Adapted For Rush App 20200331975 - Perez; Franck ; et al.	2020-10-22
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule Grant 10,752,668 - Agaugue , et al. A	2020-08-25
Immune Cells Defective For Suv39h1 App 20200171090 - AMIGORENA; Sebastian ; et al.	2020-06-04
Inhibitor Of Suv39h1 Histone Methyltransferase For Use In Cancer Combination Therapy App 20200157225 - AMIGORENA; Sebastian ; et al.	2020-05-21
Inhibitor Of Suv39h1 Histone Methyltransferase For Use In Cancer Combination Therapy App 20200147099 - AMIGORENA; Sebastian ; et al.	2020-05-14
Immune cells defective for SUV39H1 Grant 10,576,103 - Amigorena , et al.	2020-03-03
New Anti-lsp1 Antibody App 20190367635 - SEGURA; ELODIE ; et al.	2019-12-05
Immune Cells Defective For Suv39h1 App 20190365807 - AMIGORENA; Sebastian ; et al.	2019-12-05
Methods And Pharmaceutical Compositions For The Treatment Of Th2 Mediated Diseases App 20190117664 - AMIGORENA; Sebastian ; et al.	2019-04-25
Lentiviral Vectors For Regulated Expression Of A Chimeric Antigen Receptor Molecule App 20170166623 - AGAUGUE; Sophie ; et al.	2017-06-15
Methods And Pharmaceutical Compositions For The Treatment Of Th2 Mediated Diseases App 20150038496 - Amigorena; Sebastian ; et al.	2015-02-05
Antibody specific for the Tn antigen for the treatment of cancer App 20100278818 - Hubert-Haddad; Pascale ; et al.	2010-11-04
Sensitization process for antigen-presenting cells and means for implementing the process Grant 7,625,573 - Zitvogel , et al. December 1, 2	2009-12-01
Method for preparing membrane vesicles Grant 6,899,863 - Dhellin , et al. May 31, 2	2005-05-31
Compositions and methods using lactadherin or variants thereof App 20040241179 - Raposo, Graca ; et al.	2004-12-02
Sensitization process for antigen-presenting cells and means for implementing the process App 20040028692 - Zitvogel, Laurence ; et al.	2004-02-12
Sensitization process for antigen-presenting cells and means for implementing the process Grant 6,685,911 - Zitvogel , et al. February 3, 2	2004-02-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.